Géndeletiók molekuláris diagnosztikai vizsgálata Duchenne- és Becker-izomdystrophiában.

Translated title of the contribution: Gene deletion analysis in molecular diagnosis of Duchenne-Becker muscular dystrophy

E. Endreffy, A. László, M. Kálmán, T. Krenács, I. Raskó

Research output: Contribution to journalArticle

Abstract

Deletion analysis of the dystrophin gene (Xp21) was carried out by examinations of the most frequently deleted 18 exons (3., 4., 6., 8., 12., 13., 17., 19., 43., 44., 45., 47., 48., 49., 50., 51., 52. and 60. exon) and the muscle specific promoter in 42 Duchenne and Becker muscular dystrophy (DMD/BMD) affected patients with multiple polymerase chain reaction (PCR). 22 (52%) of 42 patients were found to have one or more exon deletions. 9% BMD patients (milder allelic form) were found in the deletion group versus 35% in the non deletion group. This method seems to be useful for prenatal genetic diagnosis in the family of deletion patients.

Original languageHungarian
Pages (from-to)399-403
Number of pages5
JournalOrvosi Hetilap
Volume135
Issue number8
Publication statusPublished - Feb 20 1994

Fingerprint

Duchenne Muscular Dystrophy
Gene Deletion
Exons
Dystrophin
Prenatal Diagnosis
Muscles
Polymerase Chain Reaction
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Géndeletiók molekuláris diagnosztikai vizsgálata Duchenne- és Becker-izomdystrophiában. / Endreffy, E.; László, A.; Kálmán, M.; Krenács, T.; Raskó, I.

In: Orvosi Hetilap, Vol. 135, No. 8, 20.02.1994, p. 399-403.

Research output: Contribution to journalArticle

@article{be51fa649e054d4781976c561c558b27,
title = "G{\'e}ndeleti{\'o}k molekul{\'a}ris diagnosztikai vizsg{\'a}lata Duchenne- {\'e}s Becker-izomdystrophi{\'a}ban.",
abstract = "Deletion analysis of the dystrophin gene (Xp21) was carried out by examinations of the most frequently deleted 18 exons (3., 4., 6., 8., 12., 13., 17., 19., 43., 44., 45., 47., 48., 49., 50., 51., 52. and 60. exon) and the muscle specific promoter in 42 Duchenne and Becker muscular dystrophy (DMD/BMD) affected patients with multiple polymerase chain reaction (PCR). 22 (52{\%}) of 42 patients were found to have one or more exon deletions. 9{\%} BMD patients (milder allelic form) were found in the deletion group versus 35{\%} in the non deletion group. This method seems to be useful for prenatal genetic diagnosis in the family of deletion patients.",
author = "E. Endreffy and A. L{\'a}szl{\'o} and M. K{\'a}lm{\'a}n and T. Kren{\'a}cs and I. Rask{\'o}",
year = "1994",
month = "2",
day = "20",
language = "Hungarian",
volume = "135",
pages = "399--403",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "8",

}

TY - JOUR

T1 - Géndeletiók molekuláris diagnosztikai vizsgálata Duchenne- és Becker-izomdystrophiában.

AU - Endreffy, E.

AU - László, A.

AU - Kálmán, M.

AU - Krenács, T.

AU - Raskó, I.

PY - 1994/2/20

Y1 - 1994/2/20

N2 - Deletion analysis of the dystrophin gene (Xp21) was carried out by examinations of the most frequently deleted 18 exons (3., 4., 6., 8., 12., 13., 17., 19., 43., 44., 45., 47., 48., 49., 50., 51., 52. and 60. exon) and the muscle specific promoter in 42 Duchenne and Becker muscular dystrophy (DMD/BMD) affected patients with multiple polymerase chain reaction (PCR). 22 (52%) of 42 patients were found to have one or more exon deletions. 9% BMD patients (milder allelic form) were found in the deletion group versus 35% in the non deletion group. This method seems to be useful for prenatal genetic diagnosis in the family of deletion patients.

AB - Deletion analysis of the dystrophin gene (Xp21) was carried out by examinations of the most frequently deleted 18 exons (3., 4., 6., 8., 12., 13., 17., 19., 43., 44., 45., 47., 48., 49., 50., 51., 52. and 60. exon) and the muscle specific promoter in 42 Duchenne and Becker muscular dystrophy (DMD/BMD) affected patients with multiple polymerase chain reaction (PCR). 22 (52%) of 42 patients were found to have one or more exon deletions. 9% BMD patients (milder allelic form) were found in the deletion group versus 35% in the non deletion group. This method seems to be useful for prenatal genetic diagnosis in the family of deletion patients.

UR - http://www.scopus.com/inward/record.url?scp=0028777091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028777091&partnerID=8YFLogxK

M3 - Article

VL - 135

SP - 399

EP - 403

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 8

ER -